121 related articles for article (PubMed ID: 32174243)
21. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
[TBL] [Abstract][Full Text] [Related]
22. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study.
Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C
J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
[TBL] [Abstract][Full Text] [Related]
24. Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time.
Guibal A; Bertin C; Egels S; Savier E; Grenier PA; Lucidarme O
Eur Radiol; 2013 May; 23(5):1392-400. PubMed ID: 23138387
[TBL] [Abstract][Full Text] [Related]
25. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
da Silva NPB; Beyer LP; Hottenrott MC; Hackl C; Schlitt HJ; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2017; 66(4):357-368. PubMed ID: 28598835
[TBL] [Abstract][Full Text] [Related]
26. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
27. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone.
Lekht I; Gulati M; Nayyar M; Katz MD; Ter-Oganesyan R; Marx M; Cen SY; Grant E
Abdom Radiol (NY); 2016 Aug; 41(8):1511-21. PubMed ID: 26969495
[TBL] [Abstract][Full Text] [Related]
28. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
29. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of 3D-CEUS in the Recurrence of Liver Cancer after Radiofrequency Ablation.
Bai L; Wang X; Shi S; Gao J; Li X; Wang Y; Jiang M; Zheng C; Liu H
J Healthc Eng; 2021; 2021():3123553. PubMed ID: 34966520
[TBL] [Abstract][Full Text] [Related]
32. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging.
Xu EJ; Lv SM; Li K; Long YL; Zeng QJ; Su ZZ; Zheng RQ
Int J Hyperthermia; 2018 Sep; 34(6):870-876. PubMed ID: 28847188
[TBL] [Abstract][Full Text] [Related]
33. Correlation Between Contrast-Enhanced Ultrasound and Immune Response of Distant Hepatocellular Carcinoma After Radiofrequency Ablation in a Murine Model.
Wang P; Tian M; Ren W
J Ultrasound Med; 2022 Mar; 41(3):713-723. PubMed ID: 34018628
[TBL] [Abstract][Full Text] [Related]
34. Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization.
Gu JH; Zhao QY; He C; Ye ZD; Xu M; Jiang TA
Int J Hyperthermia; 2021; 38(1):1092-1098. PubMed ID: 34296656
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous radiofrequency ablation guided by contrast-enhanced ultrasound in treatment of metastatic hepatocellular carcinoma after liver transplantation.
Dai X; Zhao HQ; Liu RH; Xu CT; Zheng F; Yu LB; Li WM
Asian Pac J Cancer Prev; 2012; 13(8):3709-12. PubMed ID: 23098459
[TBL] [Abstract][Full Text] [Related]
36. Monitoring radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: a porcine model.
Slabaugh TK; Machaidze Z; Hennigar R; Ogan K
J Endourol; 2005 Jun; 19(5):579-83. PubMed ID: 15989450
[TBL] [Abstract][Full Text] [Related]
37. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation guided by contrast-enhanced ultrasound for hepatic malignancies: preliminary results.
Dong Y; Wang WP; Gan YH; Huang BJ; Ding H
Clin Radiol; 2014 Nov; 69(11):1129-35. PubMed ID: 25060936
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced ultrasound-guided feeding artery ablation as add-on to percutaneous radiofrequency ablation for hypervascular hepatocellular carcinoma with a modified ablative technique and tumor perfusion evaluation.
Li X; Xu M; Liu M; Tan Y; Zhuang B; Lin M; Kuang M; Xie X
Int J Hyperthermia; 2020; 37(1):1016-1026. PubMed ID: 32865050
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation: First results of CEUS evaluation.
Zhao CK; Xu HX; Lu F; Sun LP; He YP; Guo LH; Li XL; Bo XW; Yue WW
Clin Hemorheol Microcirc; 2017; 65(4):393-405. PubMed ID: 27983547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]